Clover Corporation Limited (CLV.AX)
Altona North, VIC, AU
Clover Corporation Limited engages in the processing and worldwide sale of natural oils, reaching markets across Australia, New Zealand, Asia, Europe, and the Americas. The company's operations also encompass the creation of encapsulated products and extensive research and development focused on functional food and infant nutrition ingredients. Among its principal offerings are Nu-Mega Hi docosahexaenoic tuna oils, designed for use in infant formula and pharmaceutical goods, alongside its Ocean Gold refined tuna oils. Furthermore, it supplies Nu-Mega Driphorm powders, which are incorporated into various infant formulas, follow-on formulas, growing-up milks, and general food products, as well as Nu-Mega Driphorm HA for non-dairy applications. These products cater to several segments, including active living (for immune and sports support), healthy living (benefiting brain and heart health), and the foundational stages of infant and child development. The company, founded in 1988, maintains its corporate headquarters in Altona North, Australia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.72% | +7.74% | -7.18% | +16.03% | +6.47% | +14.56% | +110.47% | -25.21% | -39.26% | +115.48% | +201.67% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-02 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%+38.3% ★ Q1'26: +61.4% (vs Q1'24)
-
EPS growth Packaged Foods: +14.6%+361.5% ★ Q1'26: +768.4% (vs Q1'24)
-
FCF margin FCF growth · Packaged Foods: +15.9%+9.0% Q1'26: +10.0% (vs Q1'24)
-
EBIT margin Packaged Foods: +7.9%+12.4% ★ Q1'26: +16.0% (vs Q1'24)
-
ROIC Packaged Foods: +7.0%+10.9% ★ Q1'26: +30.6% (vs Q1'24)
-
Share dilution Packaged Foods: +0.0%+0.0% Q1'26: +0.0% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×0.20× ★ Q1'26: 0.04× (vs Q1'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jul 2014 actual |
Jul 2015 actual |
Jul 2016 actual |
Jul 2017 actual |
Jul 2018 actual |
Jul 2019 actual |
Jul 2020 actual |
Jul 2021 actual |
Jul 2022 actual |
Jul 2023 actual |
Jul 2024 actual |
Jul 2025 actual |
Jul 2026 1 Rev. Ana. 1 EPS Ana. |
Jul 2027 1 Rev. Ana. 1 EPS Ana. |
Jul 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
27.19M
est: 32.23M (-15.6%)
|
29.92M
est: 32.60M (-8.2%)
|
42.92M
est: 42.00M (+2.2%)
|
47.86M
est: 48.40M (-1.1%)
|
62.96M
est: 64.60M (-2.5%)
|
76.68M
est: 70.72M (+8.4%)
|
88.28M
est: 90.00M (-1.9%)
|
60.51M
est: 64.47M (-6.2%)
|
70.66M
est: 62.20M (+13.6%)
|
79.88M
est: 78.08M (+2.3%)
|
62.21M
est: 64.64M (-3.8%)
|
86.00M
est: 81.00M (+6.2%)
|
89.40M
89.40M – 89.40M
+10.4% YoY
|
95.30M
95.30M – 95.30M
+6.6% YoY
|
101.00M
101.00M – 101.00M
+6.0% YoY
|
| EBITDA |
1.29M
est: 4.29M (-69.9%)
|
-75.0K
est: 1.27M (-105.9%)
|
2.83M
est: 5.59M (-49.4%)
|
5.49M
est: 6.44M (-14.8%)
|
10.65M
est: 8.60M (+23.9%)
|
14.70M
est: 8.6K (+170,825.4%)
|
19.04M
est: 18.09M (+5.3%)
|
10.23M
est: 8.58M (+19.1%)
|
11.66M
est: 8.28M (+40.8%)
|
10.01M
est: 25.22M (-60.3%)
|
3.98M
est: 8.61M (-53.7%)
|
12.24M
est: 10.78M (+13.5%)
|
11.90M
11.90M – 11.90M
+10.4% YoY
|
12.69M
12.69M – 12.69M
+6.6% YoY
|
13.45M
13.45M – 13.45M
+6.0% YoY
|
| EBIT |
792.0K
est: 3.84M (-79.4%)
|
-724.0K
est: 1.26M (-157.3%)
|
2.40M
est: 5.00M (-52.0%)
|
4.92M
est: 5.76M (-14.7%)
|
9.95M
est: 7.69M (+29.3%)
|
14.29M
est: 8.6K (+166,070.7%)
|
18.36M
est: 16.34M (+12.4%)
|
9.52M
est: 7.68M (+24.0%)
|
10.95M
est: 7.41M (+47.8%)
|
9.09M
est: 27.08M (-66.4%)
|
2.82M
est: 7.70M (-63.4%)
|
10.68M
est: 9.65M (+10.7%)
|
10.65M
10.65M – 10.65M
+10.4% YoY
|
11.35M
11.35M – 11.35M
+6.6% YoY
|
12.03M
12.03M – 12.03M
+6.0% YoY
|
| Net Income |
967.0K
est: 3.20M (-69.8%)
|
100.0K
est: 996.0K (-90.0%)
|
2.21M
est: 2.17M (+1.9%)
|
3.64M
est: 4.17M (-12.8%)
|
7.59M
est: 5.84M (+29.8%)
|
10.10M
est: 215.1K (+4,596.7%)
|
12.49M
est: 12.45M (+0.3%)
|
6.00M
est: 7.22M (-16.8%)
|
7.13M
est: 5.55M (+28.6%)
|
6.21M
est: 6.21M (+0.0%)
|
1.52M
est: 601.5K (+151.9%)
|
7.02M
est: 6.68M (+5.0%)
|
8.52M
8.52M – 8.52M
+27.5% YoY
|
9.35M
9.35M – 9.35M
+9.8% YoY
|
10.19M
10.19M – 10.19M
+8.9% YoY
|
| SGA |
4.71M
est: 4.49M (+4.9%)
|
4.52M
est: 4.84M (-6.5%)
|
4.67M
est: 5.85M (-20.1%)
|
4.98M
est: 6.74M (-26.0%)
|
6.78M
est: 8.99M (-24.6%)
|
8.91M
est: 9.72M (-8.3%)
|
9.16M
est: 10.99M (-16.7%)
|
6.93M
est: 8.98M (-22.8%)
|
8.56M
est: 8.66M (-1.2%)
|
11.21M
est: 13.56M (-17.4%)
|
10.37M
est: 9.00M (+15.3%)
|
13.20M
est: 11.28M (+17.0%)
|
12.45M
12.45M – 12.45M
+10.4% YoY
|
13.27M
13.27M – 13.27M
+6.6% YoY
|
14.06M
14.06M – 14.06M
+6.0% YoY
|
| EPS |
0.01
est: 0.02 (-69.3%)
|
0.00
est: 0.01 (-94.0%)
|
0.01
est: 0.01 (+3.1%)
|
0.02
est: 0.03 (-12.0%)
|
0.05
est: 0.04 (+31.1%)
|
0.06
est: 0.05 (+11.3%)
|
0.08
est: 0.06 (+34.1%)
|
0.04
est: 0.04 (-16.4%)
|
0.04
est: 0.03 (+29.2%)
|
0.04
est: 0.03 (+23.6%)
|
0.01
est: 0.00 (+152.6%)
|
0.04
est: 0.04 (+5.0%)
|
0.05
0.05 – 0.05
+27.5% YoY
|
0.06
0.06 – 0.06
+9.8% YoY
|
0.06
0.06 – 0.06
+8.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-28 | A | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-27 | A | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-26 | A | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-25 | A | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-22 | A | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-21 | A | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-20 | A | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-19 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-18 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-15 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-06 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-05 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-04 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-01 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-24 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-23 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-22 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Peter J. Davey GAICD gradDip Bus. | Chief Executive Officer, MD & Executive Director | 831.7K | male |
| Andrew G. Allibon | Chief Financial Officer & Company Secretary | 426.6K | male |
| David Pierotti | Director of Operations | 195.7K | male |
| Anne Roach | General Manager of People & Culture | — | female |
| Bassam Hallak | Director of Sales & Marketing | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CLV.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
